Mobile

A double-blind, placebo-controlled Clinical Trial to evaluate the Safety and Efficacy of JNJ-64304500 in patients with Moderately to Severely Active Crohn’s Disease

Mise à jour : Il y a 4 ans
Référence : EUCTR2016-000634-21

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

- To evaluate the efficacy of JNJ-64304500 to reduce the CDAI score from baseline. - To evaluate the safety of JNJ-64304500.

Critère d'inclusion

  • Active Crohn's disease

Liens